mark'ennovy is a seasoned player in the fashion, health care, and medical devices industries, renowned for their expertise in crafting individually crafted contact lenses. Founded in 1997 and headquartered in Spain, this company specializes in manufacturing customized contact lenses designed to meet the unique visual needs of individuals, particularly in myopia management and presbyopia.
mark'ennovy differentiates itself by exclusively partnering with eye care professionals, ensuring a high level of professionalism and precision in the distribution of its products. This strategic approach has been further reinforced since joining the Euclid Vision Group in 2022.
For investors, it's notable that mark'ennovy secured a debt financing investment from Alantra Private Equity on 17 October 2018. This suggests a solid financial strategy and potential for sustainable growth within the optical sector. With its longstanding market presence and innovative approach, mark'ennovy presents a compelling opportunity for future investment consideration.